31 Live Births Reported Following Uterus Transplant - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

31 Live Births Reported Following Uterus Transplant

Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

  • By

  • Kathryn Wighton

  • May 6, 2026

  • 4 min

Share

Objective:

To report maternal, obstetric, and neonatal outcomes from the Baylor University Medical Center uterus transplant program.

Key Findings:
  • 31 live births occurred in 27 uterus transplant recipients, with 4 women delivering twins.
  • Clarify that maternal medical complications were reported in 30% of women who had live births.
Interpretation:

Uterus transplant is a feasible reproductive option for women with uterine-factor infertility, with generally favorable outcomes despite some maternal complications (e.g., gestational diabetes, hypertension) and obstetric complications (e.g., preterm labor).

Limitations:
  • Findings reflect a single-center experience, limiting generalizability to broader populations and settings.
  • Access to uterus transplant requires substantial time and resources, which may not be available in all healthcare systems.
Conclusion:

The data support the feasibility of uterus transplant in specialized centers, highlighting the need for ongoing reporting and data sharing to refine risk estimates.

Original Source(s)

31 Live Births Reported Following Uterus Transplant

  • by Kathryn Wighton

  • May 6, 2026

Related Content

Surgeons Describe Rescue Barriers

Interviews with surgeons linked rescue failures to hierarchy, self-reliance, communication barriers, and system pressures.

Fertility Issues May Be Linked to Autism

In a nationwide US cohort, parental subfecundity was associated with higher odds of autism spectrum disorder and modest increases in behavioral symptoms, while in vitro fertilization showed no statistically significant associations with neurodevelopmental outcomes.

Pregnancy Risks With First Trimester GLP-1 Continuation

Claims-based target trial emulation found no clear association between continued GLP-1 receptor agonist use in early pregnancy and nonlive birth, fetal growth abnormalities, or major congenital malformations.